Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules

Clinical and Experimental Immunology

Volumn 148, Issue 3, 2007, Pages 507-514

  Gao, Y H ^a   Xu, L X ^a   Zhang, J J ^a   Zhang, Y ^a   Zhao, M H ^a   Wang, H Y ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Binding capacity; Deglycosylation; Galactose; Glycosylation; IgA nephropathy; IgA1; Mesangial cell; Radioligand; Sialic acid

Indexed keywords

IMMUNOGLOBULIN A1;

ANTIGEN BINDING; ARTICLE; DEGLYCOSYLATION; ENZYME BINDING; ENZYME SPECIFICITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; IMMUNOGLOBULIN PRODUCTION; MESANGIUM CELL; PRIORITY JOURNAL; SIALYLATION;

BIOPOLYMERS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOMERULAR MESANGIUM; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A;

EID: 34247853267     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03374.x     Document Type: Article

References (39)

1. Donadio JV, Grande JP. Immunoglobulin A nephropathy: a clinical perspective. J Am Soc Nephrol 1997 8:1324 32.
2. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002 347:738 48.
3. Leung JC, Tsang AW, Chan LY, Tang SC, Lam MF, Lai KN. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells. J Lab Clin Med 2002 140:398 406.
4. Hiki Y, Tanaka A, Kokubo T et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Am Soc Nephrol 1998 9:577 82.
5. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 1999 10:1763 71.
6. Leung JC, Tang SC, Lam MF, Chan TM, Lai KN. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int 2001 59:277 85.
7. Iwase H, Katsumata T, Itoh A et al. Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients. J Nephrol 2002 15:703 8.
8. Sano T, Hiki Y, Kokubo T, Iwase H, Shigematsu H, Kobayashi Y. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol Dial Transplant 2002 17:50 6.
9. Hashim OH, Shuib AS, Chua CT. Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains. Nephron 2001 89:422 5.
10. Kerr MA. The structure and function of IgA. Biochem J 1990 271:285 96.
11. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 2005 68:167 72.
12. Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy. Clin Exp Immunol 2005 142:569 75.
13. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001 60:969 73.
14. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001 59:1077 85.
15. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985 28:666 71.
16. Trascasa ML, Egido J, Sancho J, Hernando L. IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol 1980 42:247 54.
17. Yan Y, Xu LX, Zhang JJ, Zhang Y, Zhao MH. Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy. Clin Exp Immunol 2006 144:17 24.
18. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997 52:509 16.
19. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999 104:73 81.
20. Iwase H, Yokozeki Y, Hiki Y et al. Human serum immunoglobulin G3 subclass bound preferentially to asialo-, agalactoimmunoglobulin A1/Sepharose. Biochem Biophys Re Commun 1999 264:424 9.
21. Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M. Interaction of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int 2002 62:465 75.
22. Nakamura I, Iwase H, Arai K et al. Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes. Nephrology 2004 9:26 30.
23. Moura IC, Arcos-Fajardo M, Sadaka C et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 2004 15:622 34.
24. Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY. Binding capacity and pathopyhysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 2004 136:168 75.
25. Zhang JJ, Xu LX, Zhang Y, Zhao MH. Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells. Clin Immunol 2006 119:103 9.
26. Westerhuis R, Van Zandbergen G, Verhagen NA, Klar-Mohamad N, Daha MR, van Kooten C. Human mesangial cells in culture and in kidney sections fail to express Fc alpha receptor (CD89). J Am Soc Nephrol 1999 10:770 8.
27. Iwase H, Tanaka A, Hiki Y et al. Estimation of the number of O-linked oligosaccharides per heavy chain of human serum IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide. J Biochem 1996 120:393 7.
28. Troyer DA, Kreisberg JI. Isolation and study of glomerular cells. Meth Enzymol 1990 191:141 52.
29. Greenwood FC, Hunter WM, Glover JS. The preparation of 125I labeled human growth hormone of high specific radioactivity. Biochem J 1963 89:114 23.
30. Coppo R, Amore A, Roccatello D et al. IgA antibodies to dietary antigens and lectin-binding IgA in sera from Italian, Australian and Japanese IgA nephropathy patients. Am J Kidney Dis 1991 17:480 7.
31. Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG. IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA 1982 79:6229 31.
32. Diven SC, Caflisch CR, Hammond DK, Weigel PH, Oka JA, Goldblum RM. IgA induced activation of human mesangial cells. independent of Fc alpha R (CD89). Kidney Int 1998 54:837 47.
33. Barratt J, Greer MR, Pawluczyk IZ et al. Identification of a novel Fc alpha receptor expressed by human mesangial cells. Kidney Int 2000 57:1936 48.
34. Leung JC, Tsang AW, Chan DT, Lai K. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 2000 11:241 9.
35. Moura IC, Centelles MN, Arcos-Fajardo M et al. Identification of the transferring receptor as a novel immunoglobulin (Ig) A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001 194:417 25.
36. McDonald KJ, Cameron AJ, Allen JM, Jardine AG. Expression of Fc α/ω receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy. Biochem Biophys Res Commun 2002 290:438 42.
37. Leung JC, Tang SC, Chan LY, Tsang AW, Lan HY, Lai KN. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 2003 18:36 45.
38. Gomez Guerrero C, Gonzalez E, Egido J. Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 1993 151:7172 81.
39. Kokubo T, Hiki Y, Iwase H et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 1998 9:2048 54.